ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

Obituary: I. Bernard Weinstein, 78, Of Columbia Univ.

November 14, 2008

In Brief: Steve Carter Accepts Job With Bristol, Phillips Elected NCG Chairman; Murray Copeland Dies

April 9, 1982

US Could Lose Leadership In Research If NIH Budget Is Cut, ASCO President Says

June 2, 1995

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

NCI-Approved Clinical Trials

December 31, 2004